Literature DB >> 9769170

Somitogenesis controlled by Noggin.

A Tonegawa1, Y Takahashi.   

Abstract

In vertebrates, the segmented somites, which are the medial-most component in the paraxial mesoderm, are the entity giving rise to the axial bones and skeletal muscles. We previously demonstrated that the mechanism that distinguishes the somite from the more lateral mesoderm (lateral plate) involves different levels of BMP-4 activity which is highest in the lateral plate. We report that Noggin, an antagonist of BMP-4, is expressed in the presumptive somite and appears to control effective levels of BMP-4 to differentiate somitic mesoderm from the lateral plate. When Noggin-producing cells were implanted into the presumptive lateral plate, they produced ectopic somites that were respecified from the lateral plate precursors. These somites exhibited no mediolateral (M-L) polarity, but acquired it when implanted Noggin was eliminated. Thus, in normal embryogenesis no or low BMP-4 activity realized by Noggin specifies the somites in the medial-most portion of the paraxial mesoderm, and then BMP-4 emanating from the lateral plate subsequently establishes the M-L polarity in the somites. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769170     DOI: 10.1006/dbio.1998.8895

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  20 in total

1.  An anteroposterior wave of vascular inhibitor downregulation signals aortae fusion along the embryonic midline axis.

Authors:  Robert J Garriock; Catherine Czeisler; Yasuo Ishii; Alicia M Navetta; Takashi Mikawa
Journal:  Development       Date:  2010-11       Impact factor: 6.868

2.  Role of hindbrain in inner ear morphogenesis: analysis of Noggin knockout mice.

Authors:  Jinwoong Bok; Lisa J Brunet; Omar Howard; Quianna Burton; Doris K Wu
Journal:  Dev Biol       Date:  2007-08-16       Impact factor: 3.582

3.  Myo/Nog cell regulation of bone morphogenetic protein signaling in the blastocyst is essential for normal morphogenesis and striated muscle lineage specification.

Authors:  Jacquelyn Gerhart; Victoria L Scheinfeld; Tara Milito; Jessica Pfautz; Christine Neely; Dakota Fisher-Vance; Kelly Sutter; Mitchell Crawford; Karen Knudsen; Mindy George-Weinstein
Journal:  Dev Biol       Date:  2011-08-18       Impact factor: 3.582

Review 4.  Multiple roles of timing in somite formation.

Authors:  Claudio D Stern; Agnieszka M Piatkowska
Journal:  Semin Cell Dev Biol       Date:  2015-06-24       Impact factor: 7.727

5.  A Myogenic Double-Reporter Human Pluripotent Stem Cell Line Allows Prospective Isolation of Skeletal Muscle Progenitors.

Authors:  Jianbo Wu; Nadine Matthias; Jonathan Lo; Jose L Ortiz-Vitali; Annie W Shieh; Sidney H Wang; Radbod Darabi
Journal:  Cell Rep       Date:  2018-11-13       Impact factor: 9.423

Review 6.  Making muscle: Morphogenetic movements and molecular mechanisms of myogenesis in Xenopus laevis.

Authors:  Armbien Sabillo; Julio Ramirez; Carmen R Domingo
Journal:  Semin Cell Dev Biol       Date:  2016-02-05       Impact factor: 7.727

Review 7.  Evo-devo: Hydra raises its Noggin.

Authors:  Kalpana Chandramore; Surendra Ghaskadbi
Journal:  J Biosci       Date:  2011-08       Impact factor: 1.826

8.  Noggin producing, MyoD-positive cells are crucial for eye development.

Authors:  Jacquelyn Gerhart; Jessica Pfautz; Christine Neely; Justin Elder; Kevin DuPrey; A Sue Menko; Karen Knudsen; Mindy George-Weinstein
Journal:  Dev Biol       Date:  2009-09-22       Impact factor: 3.582

9.  Notochord-derived BMP antagonists inhibit endothelial cell generation and network formation.

Authors:  Michael Bressan; Patricia Davis; John Timmer; Doris Herzlinger; Takashi Mikawa
Journal:  Dev Biol       Date:  2008-11-12       Impact factor: 3.582

10.  Follistatin interacts with Noggin in the development of the axial skeleton.

Authors:  David A Stafford; Stefanie D Monica; Richard M Harland
Journal:  Mech Dev       Date:  2014-02       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.